Genetically obese mice do not show increased gut permeability or faecal bile acid hydrophobicity

British Journal of Nutrition

Volumn 110, Issue 6, 2013, Pages 1157-1164

  Stenman, Lotta K ^a   Holma, Reetta ^a   Gylling, Helena ^b,c   Korpela, Riitta ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Bile acid; Intestinal permeability; Lipopolysaccharide binding protein; Obesity

Indexed keywords

BILE ACID; BINDING PROTEIN; DEXTRAN; FARNESOID X RECEPTOR; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; LIPOPOLYSACCHARIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUTHANASIA; FAT CONTENT; GENE EXPRESSION; HYDROPHOBICITY; INTESTINE MUCOSA PERMEABILITY; JEJUNUM; LIPID DIET; LIVER; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; OBESITY; PATHOGENESIS; PROTEIN EXPRESSION; SEROLOGY; WILD TYPE;

ACUTE-PHASE PROTEINS; ANIMALS; BILE ACIDS AND SALTS; CARRIER PROTEINS; DIETARY FATS; FECES; GENE EXPRESSION REGULATION; INTESTINES; LIPOPOLYSACCHARIDES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, OBESE; OBESITY; PERMEABILITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 84882598382     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451300024X     Document Type: Article

References (37)

1. Valenti L, Fracanzani AL & Fargion S (2009) The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease Semin Immunopathol 31, 359-369.
2. Vaarala O (2008) Leaking gut in type 1 diabetes. Curr Opin Gastroenterol 24, 701-706.
3. Miele L, Valenza V, La Torre G, et al. (2009) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49, 1877-1887.
4. Cani PD, Possemiers S, Van de Wiele T, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091-1103.
5. Blaut M & Klaus S (2012) Intestinal microbiota and obesity. In Appetite Control, 1st ed., pp. 251-273 [H-G Joost, editor]. Berlin Heidelberg: Springer-Verlag.
6. Brun P, Castagliuolo I, Di Leo V, et al. (2007) Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292, G518-G525.
7. Cani PD, Bibiloni R, Knauf C, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481.
8. Suzuki T & Hara H (2010) Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab (Lond) 7, 19.
9. de La Serre CB, Ellis CL, Lee J, et al. (2010) Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 299, G440-G448.
10. Stenman LK, Holma R & Korpela R (2012) High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World J Gastroenterol 18, 923-929.
11. Carvalho B, Guadagnini D, Tsukumo D, et al. (2012) Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 55, 2823-2834.
12. Everard A, Geurts L, Van Roye M, et al. (2012) Tetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat diet-fed mice. PLoS One 28, e33858.
13. Teixeira TFS, Souza NCS, Chiarello PG, et al. (2012) Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin Nutr 31, 735-740.
14. Pendyala S, Walker JM & Holt PR (2012) A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 142, 1100-1101e2.
15. Teixeira TFS, Collado MC, Ferreira CLLF, et al. (2012) Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res 32, 637-647.
16. Stenman LK, Holma R, Eggert A, et al. (2013) A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids. Am J Physiol Gastrointest Liver Physiol 304, G227-G234.
17. Grundy SM, Ahrens EH & Miettinen TA (1965) Quantitative isolation and gas-liquid chromatographic analysis of total fecal bile acids. J Lipid Res 6, 397-410.
18. Heuman DM (1989) Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 30, 719-730.
19. Pirinen E, Gylling H, Itkonen P, et al. (2010) Activated polyamine catabolism leads to low cholesterol levels by enhancing bile acid synthesis. Amino Acids 38, 549-560.
20. Miettinen TA (1988) Cholesterol metabolism during ketoconazole treatment in man. J Lipid Res 29, 43-51.
21. Haub S, Ritze Y, Ladel I, et al. (2011) Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice. J Pharmacol Exp Ther 339, 790-798.
22. Weiss J (2003) Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gramnegative bacteria. Biochem Soc Trans 31, 785-790.
23. Sun L, Yu Z, Ye X, et al. (2010) A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 33, 1925-1932.
24. Moreno-Navarrete JM, Ortega F, Serino M, et al. (2012) Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. Int J Obes 36, 1442-1449.
25. Akiyoshi T, Uchida K, Takase H, et al. (1986) Cholesterol gallstones in alloxan-diabetic mice. J Lipid Res 27, 915-924.
26. Ogura Y & Ayaki Y (1987) Effect of diabetes on the metabolism of chenodeoxycholic acid in isolated perfused rat liver. Biol Chem Hoppe Seyler 368, 813-818.
27. Chiang JYL (2009) Bile acids: regulation of synthesis. J Lipid Res 50, 1955-1966.
28. Martin SchmittJ IV, Minkenberg A, et al. (2010) Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice. Biol Chem 391, 1441-1449.
29. Liang CP & Tall AR (2001) Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver. J Biol Chem 276, 49066-49076.
30. Sabeva NS, Rouse EJ & Graf GA (2007) Defects in the leptin axis reduce abundance of the ABCG5-ABCG8 sterol transporter in liver. J Biol Chem 282, 22397-22405.
31. Cariou B, van Harmelen K, Duran-Sandoval D, et al. (2006) The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem 281, 11039-11049.
32. Lefebvre P, Cariou B, Lien F, et al. (2009) Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 89, 147-191.
33. Siegmund B, Lehr HA & Fantuzzi G (2002) Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology 122, 2011-2025.
34. Siegmund B, Sennello JA, Lehr HA, et al. (2004) Development of intestinal inflammation in double IL-10-and leptin-deficient mice. J Leukoc Biol 76, 782-786.
35. Igel M, Lindenthal B, Giesa U, et al. (2002) Evidence that leptin contributes to intestinal cholesterol absorption in obese (ob/ob) mice and wild-type mice. Lipids 37, 153-157.
36. Hyogo H, Roy S, Paigen B, et al. (2002) Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts. J Biol Chem 277, 34117-34124.
37. Hyogo H, Roy S & Cohen DE (2003) Restoration of gallstone susceptibility by leptin in C57BL/6J ob/ob mice. J Lipid Res 44, 1232-1240.